Quality of Life Impact of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma

BACKGROUND: Sézary syndrome (SS) and mycosis fungoides (MF), types of cutaneous T-cell lymphomas (CTCL), cause significant morbidity and adversely affect quality of life (QoL). This study assessed QoL measurement changes in patients receiving mogamulizumab versus vorinostat. PATIENTS AND METHODS: A...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Lymphoma Myeloma Leuk
Autori principali: Porcu, Pierluigi, Hudgens, Stacie, Horwitz, Steven, Quaglino, Pietro, Cowan, Richard, Geskin, Larisa, Beylot-Barry, Marie, Floden, Lysbeth, Bagot, Martine, Tsianakas, Athanasios, Moskowitz, Alison, Huen, Auris, Dreno, Brigitte, Dalle, Stéphane, Caballero, Dolores, Leoni, Mollie, Dale, Stephen, Herr, Fiona, Duvic, Madeleine
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7878351/
https://ncbi.nlm.nih.gov/pubmed/33158772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2020.09.003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi